Corton Capital Inc. Day One Biopharmaceuticals, Inc. Transaction History
Corton Capital Inc.
- $81.2 Million
- Q2 2025
A detailed history of Corton Capital Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 24,411 shares of DAWN stock, worth $148,907. This represents 0.19% of its overall portfolio holdings.
Number of Shares
24,411
Previous 16,447
48.42%
Holding current value
$148,907
Previous $130,000
21.54%
% of portfolio
0.19%
Previous 0.45%
Shares
3 transactions
Others Institutions Holding DAWN
# of Institutions
197Shares Held
77MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$39.2 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$36.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$35.1 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$27.7 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$24.8 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $448M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...